СИНТЕТИЧЕСКИЕ И ПРИРОДНЫЙ ИНГИБИТОР ЛИПООКСИГЕНАЗЫ
Article Sidebar
Main Article Content
Аннотация:
Воспалительное заболевание кишечника (ВЗК) это заболевания, при котором кишечник подвергается воспалению. Точная причина ВЗК остается неясной, но общепризнано, что ее этиопатология является многофакторной
Article Details
Как цитировать:
Библиографические ссылки:
Elson CO. Experimental models of intestinal inflammation: New insights into mechanisms of mucosal homeostasis In: Ogra PL, Mestecky J, Lamm ME, Strober W, Bienenstock J, McGhee JR, eds. Mucosal Immunology, 2nd ed San Diego, CA: Academic Press; 1999:1007–1033. [Google Scholar]
German AJ, Hall EJ, Day MJ. Chronic intestinal inflammation and intestinal disease in dogs. J Vet Intern Med 2003;17:8–20. [PubMed] [Google Scholar]
Mizoguchi A, Mizoguchi E, Bhan AK. Immune networks in animal models of inflammatory bowel disease. Inflamm Bowel Dis 2003;9:246–59. [PubMed] [Google Scholar]
Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF. Ulcerative colitis. Lancet. (2017) 389:1756–70. doi: 10.1016/S0140-
(16)32126-2
PubMed Abstract | CrossRef Full Text | Google Scholar
Ocansey DKW, Zhang L, Wang Y, Yan Y, Qian H, Zhang X, et al. Exosome-mediated effects and applications in inflammatory bowel disease. Biol Rev Camb Philos Soc. (2020) 95:1287–307. doi: 10.1111/brv.12608).
(Funk CD. Prostaglandins and leukotrienes: Advances in eicosanoid biology. Science 2001;294:1871–1875. [PubMed] [Google Scholar]
Charlier C, Michaux C. Dual inhibition of cyclooxygenase‐2 (COX‐2) and 5‐lipoxygenase (5‐LOX) as a new strategy to provide safer non steroidal anti‐inflammatory drugs. Eur J Med Chem 2003;38:645–659. [PubMed] [Google Scholar]
Filimonov D.A., Druzhilovskiy D.S., Lagunin A.A., Gloriozova T.A., Rudik A.V., Dmitriev A.V., Pogodin P.V., Poroikov V.V. Komp’yuternoe prognozirovanie spektrov biologicheskoi aktivnosti khimicheskikh soedinenii: Vozmozhnosti i ogranicheniya [Computer-aided prediction of biological activity spectra for chemical compounds: Opportunities and limitations] Biomed. Chem. Res. Meth. 2018;1:e00004. doi: 10.18097/bmcrm00004. [CrossRef] [Google Scholar]
48. Filimonov D.A., Lagunin A.A., Gloriozova T.A., Rudik A.V., Druzhilovskiy D.S., Pogodin P.V., Poroikov V.V. Prediction of the biological activity spectra of organic compounds using the PASS online web resource. Chem. Heterocycl. Comp. 2014;50:444–457. doi: 10.1007/s10593-014-1496-1. [CrossRef] [Google Scholar]